Epidemiology of myelodysplastic syndromes in a French general hospital of the Basque Country

被引:20
作者
Bauduer, F [1 ]
Ducout, L
Dastugue, N
Capdupuy, C
Renoux, M
机构
[1] CH Cote Basque, Serv Malad Sang & Chimiotherapie, F-64100 Bayonne, France
[2] Ctr Hosp Cote Basque, Hop St Leon, Hematol Lab, F-64100 Bayonne, France
[3] Hop Purpan, Lab Genet Hemopathies, F-31000 Toulouse, France
关键词
myelodysplastic syndromes; epidemiology; incidence;
D O I
10.1016/S0145-2126(97)00159-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidemiologic studies concerning myelodysplastic syndromes (MDS) are rare. The estimated incidence varies between 1 and 12.6/100000/year. The aim of this work was to compare our own experience with these data. Our general hospital represents a structure with 1197 beds which serves a population of 290000 individuals (French Basques). Most of the inhabitants live in a rural environnement. Twenty percent of the population are aged over 65. During a 4-year period (1993-1996), 90 new cases of MDS were diagnosed on bone marrow studies in our laboratory. Among FAB subtypes refractory anemia (RA) represented 27 cases (31%), RA with ring sideroblasts (RARS): 21 (23%), RA with excess of blasts (RAEB) and in transformation (RAEB-t): 22 (24%), chronic myelomonocytic leukemia (CMML): 10 (11%). Ten cases were unclassifiable (11%). Therapy-related MDS were seen in 8 patients. The sex ratio was 1 and the mean age of the patients was 74.3 (range: 23-96), 37% of them being 80 years or older. The calculated incidence was 7.7/100000/year for the entire cohort and 31.4/100000/year for people over 65. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:205 / 208
页数:4
相关论文
共 11 条
[1]   AGE-RELATED INCIDENCE AND OTHER EPIDEMIOLOGIC ASPECTS OF MYELODYSPLASTIC SYNDROMES [J].
AUL, C ;
GATTERMANN, N ;
SCHNEIDER, W .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :358-367
[2]  
AUL C, 1992, LEUKEMIA, V6, P52
[3]  
BAUDUER F, 1997, HEMATOLOGIE, V3, P69
[4]   PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) :189-199
[5]  
Cartwright RA, 1992, MYELODYSPLASTIC SYND, P23
[6]   Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population [J].
Maynadie, M ;
Verret, C ;
Moskovtchenko, P ;
Mugneret, F ;
Petrella, T ;
Caillot, D ;
Carli, PM .
BRITISH JOURNAL OF CANCER, 1996, 74 (02) :288-290
[7]   ESTABLISHING THE INCIDENCE OF MYELODYSPLASIA SYNDROME [J].
PHILLIPS, MJ ;
CULL, GM ;
EWINGS, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) :896-897
[8]  
RADLUND A, 1995, EUR J HAEMATOL, V54, P153
[9]  
REIZENSTEIN P, 1991, ANTICANCER RES, V11, P1069
[10]  
SHIMIZU H, 1995, INT J HEMATOL, V61, P17